The Effect of C-Reactive Protein Levels, Neutrophil, and Lymphocyte Count to Mortality of COVID-19 Patients with Sepsis in Referral Hospital
Downloads
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by infection of Severe Acute Respiratory
Distress Syndrom Coronavirus-2 (SARS CoV-2). COVID-19 patients may develop sepsis, the disregulation of
the immune system that causes organ dysfunction and life-threatening situations. High mortality of COVID-19
and sepsis make it important to study. The purpose of this study is to analyze the effect of CRP levels, neutrophil,
and lymphocyte count to mortality of COVID-19 patients with sepsis. This study is an analytic observational study
with a cross-sectional approach. Samples were randomly retrieved of COVID-19 patients with sepsis admitted
in referral hospital. Univariate, bivariate, and multivariate analysis used SPSS 26th version of Windows. The
results of this study indicate a significant effect of CRP levels and neutrophil count on mortality of COVID-19
patients with sepsis. Meanwhile, lymphocyte count had no significant effects. The multivariate analysis showed
its significance value. Partially, the effect of neutrophils on the patient's mortality has a significant value. The
conclusion of this study is CRP levels and neutrophil count simultaneously have an effect on higher mortality of
COVID-19 patients with sepsis.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls [Internet]. 2022 Feb 5 [cited 2022 Mar 23]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
Shi Y, Wang G, Cai X peng, Deng J wen, Zheng L, Zhu H hong, et al. An overview of COVID-19. J Zhejiang Univ Sci B [Internet]. 2020 May 1 [cited 2023 May 14];21(5):343. Available from: /pmc/articles/PMC7205601/
Burhan E, Susanto AD, Nasution SA, Eka G, Pitoyo ceva W, Susilo A, et al. Pedoman Tatalaksana Covid-19. 4th ed. Jakarta; 2022. 79–85 p.
Abumayyaleh M, Nuñez-Gil IJ, El-Battrawy I, Estrada V, Becerra-Muñoz VM, Uribarri A, et al. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score. Front Med. 2021;8(October):1–10.
Liwang F, Yuswar PW, Wijaya E, Sanjaya NP. Kapita Selekta Kedokteran. 5th ed. Jakarta: Media Aesculapius; 2020.
Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septik shock. Nature Reviews. 2016;
Nehring SM, Goyal A, Bansal P, Patel BC. C Reactive Protein. StatPearls [Internet]. 2021 Dec 28 [cited 2022 Feb 23];65(5):237–44. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441843/
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9.
Tortora GJ, Derrickson B. Dasar Anatomi & Fisiologi. 13th ed. Jakarta: EGC; 2017.
Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 Apr 30 [cited 2022 Mar 20];382(18):1708–20. Available from: https://pubmed.ncbi.nlm.nih.gov/32109013/
Zhao Y, Nie HX, Hu K, Wu XJ, Zhang YT, Wang MM, et al. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty [Internet]. 2020 Aug 3 [cited 2022 Mar 20];9(1). Available from: /pmc/articles/PMC7396941/
Wardika IK, Sikesa IGPH. Pengukuran Interleukin-6 (IL-6), C-Reactive Protein (CRP) dan D-Dimer sebagai prediktor prognosis pada pasien COVID-19 gejala berat: sebuah tinjauan pustaka. Intisari Sains Medis. 2021;12(3):901.
Ryoo SM, Han KS, Ahn S, Shin TG, Hwang SY, Chung SP, et al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational study. Sci Rep. 2019;9(1):1–8.
Anush MM, Ashok VK, Sarma RIN, Pillai SK. Role of c-reactive protein as an indicator for determining the outcome of sepsis. Indian J Crit Care Med. 2019;23(1):11–4.
Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;
Tufan ZK, Aslan BK, Mer M. Covid-19 and Sepsis. Turkish Journal of Medical Sciences. 2021;
Lin M, Zhang L, Tang X, Tang Y. The Value of Neutrophil/Lymphocyte Ratio Combined with Red Blood Cell Distribution Width in Evaluating the Prognosis of Emergency Patients with Sepsis. Emerg Med Int [Internet]. 2022 Nov 10 [cited 2023 Sep 29];2022:1–5. Available from: /pmc/articles/PMC9671714/
Sinurat TR. Dinutanayo WW, Aditya AA. Puromo A. Perbandingan derajat keparahan terhadap jumlah neutrofil, limfosit dan. J Vokasi Kesehat. 2022;134–9.
Tarigan LL, Silaen JC, Silalahi M. Korelasi Profil Hematologi 24 Jam Pertama Terhadap Mortalitas Pasien COVID-19 di Rumah Sakit Murni Teguh Memorial Kota Medan Tahun 2020. JURNAL PANDU HUSADA. 2023 Oct 30;4(4):50-7.
Shen XF, Cao K, Jiang JP, Guan WX, Du JF. Neutrophil dysregulation during sepsis: an overview and update. J Cell Mol Med [Internet]. 2017 Sep 1 [cited 2022 Jun 1];21(9):1687–97. Available from: https://pubmed.ncbi.nlm.nih.gov/28244690/
Pertiwi D, A. AP, Rahayu. Hubungan Antara Neutrophil Lymphocyte Ratio dan Absolute Lymphocyte Count dengan Mortalitas Pasien Covid -19. Medica Arter. 2022;4(1).
Lehman HK, Segal BH. The role of neutrophils in host defense and disease. J Allergy Clin Immunol [Internet]. 2020 Jun 1 [cited 2023 May 14];145(6):1535. Available from: /pmc/articles/PMC8912989/
Ma Y, Zhang Y, Zhu L. Role of neutrophils in acute viral infection. Immunity, Inflamm Dis. 2021;9(4):1186–96.
Park I, Kim M, Choe K, Song E, Seo H, Hwang Y, et al. Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury. Eur Respir J [Internet]. 2019;53(3).
Desnawisk F. Hubungan Antara Jumlah Leukosit, Neutrofil, dan Limfosit dengan Outcome pada Pasien Sepsis yang Dirawat di Rumah Sakit Dr. Saiful Anwar Malang. Universitas Brawijaya. 2020;
Zalfa AAA. Uji Diagnosis Neutrofil, Limfosit Dan RasioNeutrofil Limfosit (NLR) Pada Penderita COVID-19. Universitas Brawijaya. 2021;
Vahedi HSM, Bagheri A, Jahanshir A, Seyedhosseini J, Vahidi E. Association of Lymphopenia with Short Term Outcomes of Sepsis Patients; a Brief Report. Arch Acad Emerg Med. 2019;7(1):e14.
Fitriani EC, Amalia Y, Diah Andriana. Hubungan Kadar Dan Hitung Jenis Leukosit Pada Angka Mortalitas Neonatus Dan Bayi Akibat Sepsis Di Kabupaten Malang. Fak Kedokt Univ Islam Malang. 2019;183–9.
Martins EC, Da Fe Silveira L, Viegas K, Beck AD, Júnior GF, Cremonese RV, et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in anintensive care unit: a case-control study. Rev Bras Ter Intensiva [Internet]. 2019 [cited 2023 May 14];31(1):63. Available from: /pmc/articles/PMC6443306/
Kurniawan J, Asdie RH, Subronto YW. Limfopenia Persisten sebagai Prediktor Mortalitas pada Pasien Sepsis di RSUP Dr. Sardjito [Internet]. Universitas Gadjah Mada. 2019;
Nurhayatun E, Prabowo NA, Harioputro DR, Putranto W, Indarto D, Purwanto B. Neutrophil to Lymphocyte Ratio and Hs-CRP Predict Mortality in COVID-19 Patients. Proc 4th Int Conf Sustain Innov 2020–Health Sci Nurs (ICoSIHSN 2020) [Internet]. 2021 Jan 16 [cited 2023 May 14];33:80–2. Available from: https://www.atlantis-press.com/proceedings/icosihsn-20/125951154
Copyright (c) 2024 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution — You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
